Annual CFO:
-$292.37M-$104.21M(-55.38%)Summary
- As of today, DYN annual cash from operations is -$292.37 million, with the most recent change of -$104.21 million (-55.38%) on December 31, 2024.
- During the last 3 years, DYN annual cash from operations has fallen by -$172.81 million (-144.53%).
- DYN annual cash from operations is now -6921.35% below its all-time high of -$4.16 million, reached on December 31, 2018.
Performance
DYN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$90.78M+$3.92M(+4.14%)Summary
- As of today, DYN quarterly cash from operations is -$90.78 million, with the most recent change of +$3.92 million (+4.14%) on September 30, 2025.
- Over the past year, DYN quarterly cash from operations has dropped by -$16.15 million (-21.64%).
- DYN quarterly cash from operations is now -2161.56% below its all-time high of -$4.01 million, reached on December 31, 2019.
Performance
DYN Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$375.71M-$16.15M(-4.49%)Summary
- As of today, DYN TTM cash from operations is -$375.71 million, with the most recent change of -$16.15 million (-4.49%) on September 30, 2025.
- Over the past year, DYN TTM cash from operations has dropped by -$132.67 million (-54.59%).
- DYN TTM cash from operations is now -9259.99% below its all-time high of -$4.01 million, reached on December 31, 2019.
Performance
DYN TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DYN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -55.4% | -21.6% | -54.6% |
| 3Y3 Years | -144.5% | -112.1% | -146.3% |
| 5Y5 Years | -2370.6% | - | - |
DYN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -144.5% | at low | -211.0% | +14.3% | -150.8% | at low |
| 5Y | 5-Year | -2370.6% | at low | -393.6% | +14.3% | -1775.2% | at low |
| All-Time | All-Time | -6921.4% | at low | -2161.6% | +14.3% | -9260.0% | at low |
DYN Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$90.78M(+4.1%) | -$375.71M(-4.5%) |
| Jun 2025 | - | -$94.70M(+10.6%) | -$359.56M(-12.5%) |
| Mar 2025 | - | -$105.89M(-25.6%) | -$319.73M(-9.4%) |
| Dec 2024 | -$292.37M(-55.4%) | -$84.33M(-13.0%) | -$292.37M(-20.3%) |
| Sep 2024 | - | -$74.63M(-36.0%) | -$243.04M(-11.0%) |
| Jun 2024 | - | -$54.87M(+30.1%) | -$219.01M(+0.4%) |
| Mar 2024 | - | -$78.54M(-124.4%) | -$219.79M(-16.8%) |
| Dec 2023 | -$188.16M(-22.5%) | -$35.01M(+30.8%) | -$188.16M(-3.2%) |
| Sep 2023 | - | -$50.60M(+9.1%) | -$182.34M(-4.5%) |
| Jun 2023 | - | -$55.64M(-18.6%) | -$174.55M(-16.5%) |
| Mar 2023 | - | -$46.91M(-60.7%) | -$149.81M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$153.65M(-28.5%) | -$29.19M(+31.8%) | -$153.65M(-0.7%) |
| Sep 2022 | - | -$42.80M(-38.5%) | -$152.52M(-11.6%) |
| Jun 2022 | - | -$30.91M(+39.1%) | -$136.67M(+10.0%) |
| Mar 2022 | - | -$50.74M(-80.8%) | -$151.91M(-27.1%) |
| Dec 2021 | -$119.56M(-157.1%) | -$28.07M(-4.1%) | -$119.56M(-7.2%) |
| Sep 2021 | - | -$26.95M(+41.6%) | -$111.53M(-31.9%) |
| Jun 2021 | - | -$46.15M(-150.9%) | -$84.58M(-120.1%) |
| Mar 2021 | - | -$18.39M(+8.2%) | -$38.43M(-91.8%) |
| Dec 2020 | -$46.51M(-293.0%) | -$20.04M(-399.2%) | -$20.04M(-399.2%) |
| Dec 2019 | -$11.83M(-184.2%) | -$4.01M | -$4.01M |
| Dec 2018 | -$4.16M | - | - |
FAQ
- What is Dyne Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Dyne Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Dyne Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of DYN is -$292.37M
What is the all-time high annual cash from operations for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual cash from operations is -$4.16M
What is Dyne Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, DYN annual cash from operations has changed by -$104.21M (-55.38%)
What is Dyne Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of DYN is -$90.78M
What is the all-time high quarterly cash from operations for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly cash from operations is -$4.01M
What is Dyne Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, DYN quarterly cash from operations has changed by -$16.15M (-21.64%)
What is Dyne Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of DYN is -$375.71M
What is the all-time high TTM cash from operations for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high TTM cash from operations is -$4.01M
What is Dyne Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, DYN TTM cash from operations has changed by -$132.67M (-54.59%)